# OnCo record paper-sirolimus-ehe-stacchiotti-cancer-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-sirolimus-ehe-stacchiotti-cancer-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-sirolimus-ehe-stacchiotti-cancer-2021" ;
  schema:name "Activity of sirolimus in progressive epithelioid haemangioendothelioma (Italian Rare Cancer Network)"@en ;
  schema:description "In patients with progressing epithelioid haemangioendothelioma, the mTOR inhibitor sirolimus stabilised the disease in most, with a median progression-free survival of about a year, but did not help patients who had developed serosal effusions."@en ;
  schema:url <https://onco.cc/key-papers/paper-sirolimus-ehe-stacchiotti-cancer-2021/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1002/cncr.33247>, <https://pubmed.ncbi.nlm.nih.gov/33107985/> ;
  schema:sameAs <https://doi.org/10.1002/cncr.33247> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Stacchiotti S, Simeone N, Lo Vullo S, et al." ;
  onco:cancers <https://onco.cc/cancers/epithelioid-haemangioendothelioma/> ;
  onco:journals <https://onco.cc/journals/cancer-wiley/> .